Evoke Pharma
Stock Forecast, Prediction & Price Target
Evoke Pharma (EVOK) stock Price Target by analysts
$18
Potential upside: 214.68%
Evoke Pharma price prediction
What is Evoke Pharma stock analysts` prediction?
Evoke Pharma stock forecast: Based on 1 Wall Street analysts` predicted price targets for Evoke Pharma in the last 3 months, the avarage price target is $18, with a high forecast of $NaN. The average price target represents a 214.68% change from the last price of $5.72.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Evoke Pharma stock Price Target by analysts
Full breakdown of analysts given Evoke Pharma price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Yale Jen Laidlaw | 0% 0/1 | 10 months ago | $18 214.68% upside | $7.08 | StreetInsider | Previous targets (0) |
Evoke Pharma Financial Estimates
Evoke Pharma Revenue Estimates
Evoke Pharma EBITDA Estimates
Evoke Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.61M N/A | $2.50M 55.03% | $5.18M 106.51% | Avg: $21.90M Low: $21.90M High: $21.90M avg. 322.80% | Avg: $32.02M Low: $32.02M High: $32.02M avg. 46.22% | ||
Net Income
% change YoY
| $-9.02M N/A | $-8.16M 9.60% | $-7.79M 4.53% | Avg: $3.23M Low: $334.30K High: $334.30K avg. 141.48% | Avg: $9.23M Low: $936.05K High: $936.05K avg. 185.55% | ||
EBITDA
% change YoY
| $-8.14M N/A | $-7.72M 5.14% | $-7.29M 5.59% | Avg: $-13.14M Low: $-13.14M High: $-13.14M avg. -80.22% | Avg: $-19.21M Low: $-19.21M High: $-19.21M avg. -46.22% | ||
EPS
% change YoY
| -$3.37 N/A | -$2.6 22.84% | -$27.97 -975.76% | Avg: $0.1 Low: $0.1 High: $0.1 avg. 100.35% | Avg: $0.28 Low: $0.28 High: $0.28 avg. 180% | ||
Operating Expenses
% change YoY
| $9.44M N/A | $9.92M 5.11% | $12.40M 25.04% | Avg: $1.27B Low: $1.27B High: $1.27B avg. 10205.88% | Avg: $1.87B Low: $1.87B High: $1.87B avg. 46.22% | ||
FAQ
What is Evoke Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 163.52% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is 334.30K, average is 3.23M and high is 334.30K.
What is Evoke Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 184.51% in 2025-2026.
We have gathered data from 1 analysts. Their low revenue estimate is $21.90M, average is $21.90M and high is $21.90M.
What is Evoke Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 140.17% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.1, average is $0.1 and high is $0.1.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Evoke Pharma stock. The most successful analyst is Yale Jen.